文献速递慢性静脉疾病

近期浅静脉血栓患者大隐静脉消融安全性:倾向匹配队列分析

Safety of Great Saphenous Vein Ablation in Patients with Recent Superficial Venous Thrombosis: A Propensity-Matched Cohort Analysis.
PubMed 文献 · Ann Vasc Surg · 2026-07-18

结果显示术后急性深静脉血栓、血栓性浅静脉炎和静脉热诱导血栓形成无显著差异,新发或加重浅静脉血栓罕见(1/158,0.6%),提示近期浅静脉血栓患者不应延迟干预。

要点

  • 近期浅静脉血栓患者术后急性深静脉血栓、静脉热诱导血栓形成风险与无血栓史者相当。
  • 新发或加重浅静脉血栓罕见(1/158,0.6%),两组无差异。
  • 近期浅静脉血栓患者等待手术时间更短(35 vs 52天,P=0.005)。

核心结论

  • 近期同侧浅静脉血栓患者行大隐静脉消融安全,新发或加重浅静脉血栓罕见且与无血栓史者无差异。

主要发现

  • 无浅静脉血栓史组与近期浅静脉血栓组术前静脉临床严重程度评分无差异(6.4 vs 7.3,P=0.09)。
  • 近期浅静脉血栓组术后血栓性浅静脉支发生比例更高(59.5% vs 30.4%,P<0.001)。
  • 两组术后急性深静脉血栓(P=0.65)、静脉热诱导血栓形成(P=0.17)和浅静脉血栓(P=0.32)无显著差异。

关键数值与推荐

  • 新发或加重浅静脉血栓发生率1/158(0.6%),两组无差异(P=0.32)。
  • 近期浅静脉血栓定义为消融术前3个月内临床诊断的同侧浅静脉血栓。

临床怎么用

  • 近期同侧浅静脉血栓不应作为延迟大隐静脉消融的理由。
  • 术后需关注血栓性浅静脉支的发生,但急性深静脉血栓风险未见升高。

局限性

  • 回顾性单中心设计,样本量有限(共158例),结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovenous ablation of the great saphenous vein (GSV) has traditionally been approached with caution or even delayed in patients with a recent history of superficial venous thrombosis (SVT) due to concern for postprocedural complications. Scant literature has substantiated this theoretical concern. The objective of this study was to characterize the safety of GSV ablation in patients with a recent history of SVT. METHODS: This single-center retrospective cohort study included patients who underwent a GSV ablation with or without concomitant microphlebectomy from March 2016 to December 2023 at an institutional accredited outpatient vein center. Patients were grouped into 2 cohorts: (1) no history of ipsilateral SVT and (2) a recent history of ipsilateral SVT, defined as a clinical diagnosis within 3 months of GSV ablation. Patients with no history of SVT were propensity-score-matched 1:1 to those with a recent history of ipsilateral SVT using nearest-neighbor matching based on the following covariates: age, sex, race, insurance status, history of deep venous thrombosis (DVT), and use of preoperative anticoagulation. The primary end point was postprocedural acute DVT. Secondary end points included new or worsening SVT, endovenous heat-induced thrombosis (EHIT), and the time interval between the office visit recommending intervention and the procedural date. RESULTS: Seventy-nine patients with no history of SVT and 79 patients with a recent history of SVT were included. Among the 158 total patients, 46.2% of patients underwent isolated GSV ablation, 45.6% underwent GSV ablation with concomitant microphlebectomy, and 8.2% underwent GSV ablation with staged microphlebectomy. There was no difference in the preoperative Venous Clinical Severity Score between the 2 cohorts (6.4 vs. 7.3, P = 0.09). Patients without SVT had the longer waiting period from the office visit that planned the procedure to the intervention date (52 vs. 35 days, P = 0.005). Postoperatively, those with a recent SVT were more likely to have thrombosed superficial tributaries (30.4% vs. 59.5%, P < 0.001). There were no significant differences in other postoperative outcomes including acute DVT (P = 0.65), endothermal heat-induced thrombosis (EHIT) (P = 0.17), or SVT (P = 0.32). CONCLUSION: New or worsening SVT was rare (1/158, 0.6%) and did not differ between cohorts (P = 0.32); accordingly, intervention in these patients should not be delayed. Moreover, our findings show that there were no differences in procedural outcomes between patients with recent SVT and patients without SVT.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Harish KB, McGevna MA, Sehgal VS, et al. Safety of Great Saphenous Vein Ablation in Patients with Recent Superficial Venous Thrombosis: A Propensity-Matched Cohort Analysis. Ann Vasc Surg. 2026. PMID: 42471051. doi:10.1016/j.avsg.2026.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。